TP53 and neoplasm: The analysis of this mouse model indicated that the p53Y217C mutation leads to the loss of many canonical WT p53 activities, notably the capacity to transactivate target genes important for tumor suppression (e.g. Bbc3, Cdkn1a, and Zmat3).